Informations:
Erreur:
ID
13646
Description
A Prospective Cohort Study to Evaluate the Oncotype DX® Test in Early Stage Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01423890
Lien
https://clinicaltrials.gov/show/NCT01423890
Mots-clés
Versions (1)
- 22/02/2016 22/02/2016 -
Téléchargé le
22 février 2016
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Breast Cancer NCT01423890
Eligibility Breast Cancer NCT01423890
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT01423890
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
invasive breast cancer
Item
women or men with histologic evidence of invasive breast cancer (ductal, lobular or mixed disease).
boolean
C0853879 (UMLS CUI [1])
mastectomy
Item
surgical resection including breast conserving surgery or modified radical mastectomy or simple mastectomy, within the last four months.
boolean
C0024881 (UMLS CUI [1])
axillary lymph nodes
Item
axillary lymph nodes assessed for tumor by:
boolean
C0729594 (UMLS CUI [1])
sentinel node biopsy; axillary node dissection
Item
(i) sentinel node biopsy, or (ii) axillary node dissection, or (iii) both
boolean
C0796693 (UMLS CUI [1])
C0193867 (UMLS CUI [2])
C0193867 (UMLS CUI [2])
axillary lymph node; micrometastases
Item
axillary lymph node assessment negative for cancer, or positive only for micrometastases (i.e., cancer <2mm by h&e stain).
boolean
C0729594 (UMLS CUI [1])
C1513276 (UMLS CUI [2])
C1513276 (UMLS CUI [2])
estrogen receptor positive
Item
tumor is estrogen receptor (er) positive.
boolean
C0034804 (UMLS CUI [1])
endocrine therapy; tamoxifen
Item
receiving or to receive adjuvant endocrine therapy (i.e., tamoxifen or aromatase inhibitor).
boolean
C1880501 (UMLS CUI [1,1])
C0677850 (UMLS CUI [1,2])
C0039286 (UMLS CUI [2])
C0677850 (UMLS CUI [1,2])
C0039286 (UMLS CUI [2])
adjuvant chemotherapy
Item
being considered for adjuvant chemotherapy.
boolean
C0085533 (UMLS CUI [1])
axillary lymph node positive
Item
axillary lymph node positive for cancer.
boolean
C0677929 (UMLS CUI [1])
advanced breast cancer inoperable
Item
patients with inoperable locally advanced breast cancer.
boolean
C3495917 (UMLS CUI [1,1])
C0205187 (UMLS CUI [1,2])
C0205187 (UMLS CUI [1,2])
metastatic breast cancer
Item
metastatic breast cancer, including local ipsilateral recurrence.
boolean
C0036525 (UMLS CUI [1,1])
C0678222 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,2])
her2 positive
Item
her2 neu positive.
boolean
C1960398 (UMLS CUI [1])
compliance
Item
physician/patient unwilling to comply with study protocol.
boolean
C1321605 (UMLS CUI [1])
informed consent
Item
inability to provide informed consent (e.g. dementia or severe cognitive impairment).
boolean
C0021430 (UMLS CUI [1])